Form 8-K - Current report:
SEC Accession No. 0001193125-26-121811
Filing Date
2026-03-24
Accepted
2026-03-24 16:09:28
Documents
10
Period of Report
2026-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmea-20260324.htm   iXBRL 8-K 43542
2 EX-99.1 bmea-ex99_1.htm EX-99.1 123416
  Complete submission text file 0001193125-26-121811.txt   283999

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bmea-20260324.xsd EX-101.SCH 24869
13 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20260324_htm.xml XML 4691
Mailing Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 26786263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)